Don’t expect every GP stakes manager and their dog to be listing a portfolio of stakes in alternatives managers anytime soon.
GPs can be at the mercy of even the weakest connections to adherence to ESG standards – real or perceived.
Highlighting the merits of private equity ownership can be a complex exercise, and one that’s even more pertinent as the industry seeks to widen its investor base.
Following last week’s IPCC report, investors should stress-test their portfolios against realistic internal carbon pricing, boost allocations to energy transition strategies and consider divesting from carbon-intensive assets.
Capital from domestic, Middle Eastern and Asian sovereigns has propped up Russian private equity for at least half a decade.
Our A-Z demonstrates there are plenty of opportunities in the health sector provided you can find your niche.
The mid-market firm's troubles highlight the rare risk of members of a GP not seeing eye-to-eye on what's best for their LPs.
Our crystal ball told us that dealmaking would rebound in 2021, but we didn’t expect the first half to be so big.
Private equity needs to address inequities in pay before talented women and people of colour head for the exits.
Apollo’s foray into GP stakes investing is unusual for a number of reasons, not least because the deal involves a significant element of reciprocity between the firm and its target partner.